Zimmer Biomet Holdings Stock News

Key Players covered in the Knee Replacement Market Research Report are Zimmer Biomet (Indiana, U.S.), Stryker (Michigan, U.S.), DePuySynthes Companies (Johnson & Johnson Services, Inc.) (Indiana, U.S.), Smith & Nephew (London, U.K.), Aesculap, Inc. a B. Braun company (Center Vally, USA), Medacta International (Castel San Pietro, Switzerland), MicroPort Scientific Corporation (Shanghai, China), Conformis (Massachusetts, U.S.), Other Prominent Players. Key Players covered in the Knee Replacement Market Research Report are Zimmer Biomet (Indiana, U.S.), Stryker (Michigan, U.S.), DePuySynthes Companies (Johnson & Johnson Services, Inc.) (Indiana, U.S.), Smith & Nephew (London, U.K.), Aesculap, Inc. a B. Braun company (Center Vally, USA), Medacta International (Castel San Pietro, Switzerland), MicroPort Scientific Corporation (Shanghai, China), Conformis (Massachusetts, U.S.), Other Prominent Players.

Gofen & Glossberg LLC IL trimmed its stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 4.3% in the 3rd quarter, HoldingsChannel reports. The firm owned 5,209 shares of the medical equipment providers stock after selling 236 shares during the quarter. Gofen & Glossberg LLC ILs holdings in Zimmer Biomet were worth $762,000 at the end []

Overview: Surgical robots allow doctors to perform complex procedures with more precision, flexibility, and control than traditional techniques. Robotic technology is helpful because of the smaller incisions, which result in less postoperative pain, lower morbidity, and shorter hospital stays, which is

Stem cell concentration system further helps to obtain viability and proliferative potential of stem cell expected to gaining more traction and drive the stem cell concentration system market. The Global Stem Cell Concentration System Market Report provides planned insights into the

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) reached a new 52-week low during trading on Tuesday . The company traded as low as $127.12 and last traded at $128.80, with a volume of 1584 shares traded. The stock had previously closed at $130.22. A number of equities research analysts recently commented on the company. Zacks Investment Research […]

Knee Cartilage Damage Repair Market research report is wide-ranging and object-oriented which is framed after the combination of an admirable industry experience, talent solutions, industry insight, and most modern tools and technology. A thorough analysis has been performed in this

Argus lowered shares of Zimmer Biomet (NYSE:ZBH) from a buy rating to a hold rating in a report published on Tuesday, Price Targets.com reports. A number of other equities analysts have also commented on ZBH. Canaccord Genuity reduced their target price on shares of Zimmer Biomet from $190.00 to $185.00 and set a buy rating []

IFP Advisors Inc grew its position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 47.9% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 1,828 shares of the medical equipment providers stock after purchasing an additional 592 shares during the period. IFP Advisors []

Total Knee Arthroplasty Market has witnessed continuous growth in the past few years and is projected to grow even further during the forecast period (2021-2028). The research presents a complete assessment of the market and contains Future trend, Current Growth

The third quarter brings greater COVID-related pressure than expected for Zimmer Biomet (ZBH).

Marshall Wace LLP cut its holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 70.7% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 24,669 shares of the medical equipment providers stock after selling 59,429 shares during the quarter. Marshall Wace LLPs holdings in []

Zimmer Biomet (NYSE:ZBH) updated its FY 2021 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of $7.320-$7.470 for the period, compared to the Thomson Reuters consensus estimate of $7.700. The company issued revenue guidance of $7.82 billion-$7.90 billion, compared to the consensus revenue estimate of $8.05 billion. A number of brokerages []

A prosthetic is an artificial part of the body, and when you are discussing a dental implant prosthetic, you are referring to two different parts, the metal insert that connects to the jawbone and the actual tooth itself. Worldwide Market Reports

The Spinal Trauma Devices market is a comprehensive market research report which provides market analysis with a historical & futuristic perspective for the following parameters; market size, revenue, demand, and supply data (as applicable). The report offers a detailed market